Possible prevention strategy
There are 2 licensed Ebola vaccines to date. EVERBO and a second new vaccine delivered in 2 doses called Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo) for individuals 1 year and older. The Ervebo vaccine has been shown to be effective in protecting people from the species Zaire ebolavirus and is recommended by the Strategic Advisory Group of Experts on Immunization as part of a broader set of Ebola outbreak response tools (WHO, 2024)
Other prevention strategies include:
- Washing hands
- Avoid touching the body fluids of people who have, or may have, Ebola.
- Not touching the bodies of people who have died from Ebola.
- Getting the Ebola vaccine if they are at risk for the Zaire type of Ebola.
Reduced human transmission of the Ebola virus can be achieved through increasing public knowledge of risk factors and preventive interventions (vaccination included). Messages about risk reduction should emphasize the following: Reducing the risk of wildlife-to-human transmission
- Reducing the risk of human-to-human transmission
- Outbreak containment measures, including safe and dignified burial of the dead.
- Reducing the risk of possible sexual transmission
- Reducing the risk of transmission from pregnancy-related fluids and tissue.
